• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞毒性 T 淋巴细胞相关抗原-4 对脂肪酸结合蛋白疫苗防治…疗效的影响

Effect of Cytotoxic T-Lymphocyte Antigen-4 on the Efficacy of the Fatty Acid-Binding Protein Vaccine Against .

机构信息

Wuchang Hospital, Affiliated to Wuhan University of Science and Technology, Wuhan, China.

Department of Clinical Laboratory, Wuhan Fourth Hospital, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Immunol. 2019 May 7;10:1022. doi: 10.3389/fimmu.2019.01022. eCollection 2019.

DOI:10.3389/fimmu.2019.01022
PMID:31134084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6514142/
Abstract

The present study evaluated the impact of blocking cytotoxic T-lymphocyte antigen-4 (CTLA-4) activity on the protective effect elicited by the fatty acid binding protein (FABP) vaccine against infection. Mice were randomly divided into uninfected, infected control, anti-CTLA-4 monoclonal antibody (anti-CTLA-4 mAb), FABP, and combination (anti-CTLA-4 mAb and FABP) groups. An assessment of the worm and egg burden in the infected mice revealed that the worm reduction-rate induced by FABP administration was increased from 26.58 to 54.61% by co-administration of the monoclonal anti-CTLA antibody (anti-CTLA-4 mAb). Furthermore, the regulatory T cell (Treg) percentage was significantly increased in mice after administration of the anti-CTLA-4 mAb, but not the FABP vaccine, and elevated levels of the cytokines interferon (IFN)-γ, interleukin (IL)-2, IL-4, and IL-5 were observed in infected mice that were administered the anti-CTLA-4 mAb. Notably, the diameter of egg granulomas in the anti-CTLA-4 mAb and combination groups was significantly increased compared to that observed in the infected control group. Together, these results suggest that co-administering the FABP vaccine and anti-CTLA-4 treatment may have synergistically increased the immunoprotective effect of the FABP vaccine by promoting T-helper 1-type immune responses, while incurring increased tissue damage.

摘要

本研究评估了阻断细胞毒性 T 淋巴细胞相关抗原 4(CTLA-4)活性对脂肪酸结合蛋白(FABP)疫苗预防 感染的保护作用的影响。将小鼠随机分为未感染组、感染对照组、抗 CTLA-4 单克隆抗体(抗 CTLA-4 mAb)组、FABP 组和联合(抗 CTLA-4 mAb 和 FABP)组。评估感染小鼠中的 虫体和卵负荷发现,FABP 给药时诱导的虫体减少率由单独给药时的 26.58%增加到 54.61%,同时联合使用抗 CTLA-4 mAb。此外,抗 CTLA-4 mAb 给药后调节性 T 细胞(Treg)的比例显著增加,但 FABP 疫苗没有,并且在感染小鼠中观察到干扰素(IFN)-γ、白细胞介素(IL)-2、IL-4 和 IL-5 等细胞因子水平升高。值得注意的是,与感染对照组相比,抗 CTLA-4 mAb 组和联合组的卵肉芽肿直径显著增加。综上所述,FABP 疫苗和抗 CTLA-4 联合治疗可能通过促进 Th1 型免疫反应协同增强 FABP 疫苗的免疫保护作用,同时导致组织损伤增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd7/6514142/bde5310487b4/fimmu-10-01022-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd7/6514142/c23affdf3f1c/fimmu-10-01022-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd7/6514142/ea850e8bd31e/fimmu-10-01022-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd7/6514142/bde5310487b4/fimmu-10-01022-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd7/6514142/c23affdf3f1c/fimmu-10-01022-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd7/6514142/ea850e8bd31e/fimmu-10-01022-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd7/6514142/bde5310487b4/fimmu-10-01022-g0003.jpg

相似文献

1
Effect of Cytotoxic T-Lymphocyte Antigen-4 on the Efficacy of the Fatty Acid-Binding Protein Vaccine Against .细胞毒性 T 淋巴细胞相关抗原-4 对脂肪酸结合蛋白疫苗防治…疗效的影响
Front Immunol. 2019 May 7;10:1022. doi: 10.3389/fimmu.2019.01022. eCollection 2019.
2
Anti-CTLA-4 monoclonal antibody improves efficacy of the glyceraldehyde-3-phosphate dehydrogenase protein vaccine against Schistosoma japonicum in mice.抗 CTLA-4 单克隆抗体提高了甘油醛-3-磷酸脱氢酶蛋白疫苗对日本血吸虫感染小鼠的疗效。
Parasitol Res. 2019 Jul;118(7):2287-2293. doi: 10.1007/s00436-019-06363-1. Epub 2019 Jun 5.
3
Effect of regulatory T cells on the efficacy of the fatty acid-binding protein vaccine against Schistosoma japonicum.调节性 T 细胞对脂肪酸结合蛋白疫苗防治日本血吸虫效果的影响。
Parasitol Res. 2019 Feb;118(2):559-566. doi: 10.1007/s00436-018-6186-y. Epub 2019 Jan 4.
4
Administration of anti-CTLA-4 monoclonal antibody augments protective immunity induced by Schistosoma japonicum glutathione-S-transferase.抗 CTLA-4 单克隆抗体的给药增强了日本血吸虫谷胱甘肽-S-转移酶诱导的保护性免疫。
Parasite Immunol. 2019 Aug;41(8):e12657. doi: 10.1111/pim.12657. Epub 2019 Jun 17.
5
Effect of cytotoxic T-lymphocyte-associated protein 4 on CD4(+)CD25(+) regulatory T cells in murine schistosomiasis japonica.细胞毒性 T 淋巴细胞相关蛋白 4 对日本血吸虫病小鼠 CD4(+)CD25(+)调节性 T 细胞的影响。
Exp Parasitol. 2014 Jan;136:74-8. doi: 10.1016/j.exppara.2013.11.001. Epub 2013 Nov 20.
6
Effects of regulatory T cells on glyceraldehyde-3-phosphate dehydrogenase vaccine efficacy against Schistosoma japonicum.调节性 T 细胞对日本血吸虫甘油醛-3-磷酸脱氢酶疫苗疗效的影响。
Acta Trop. 2020 Feb;202:105239. doi: 10.1016/j.actatropica.2019.105239. Epub 2019 Oct 25.
7
Anti-CD25 monoclonal antibody enhances the protective efficacy of Schistosoma japonicum GST vaccine via inhibition of CD4CD25Foxp3 regulatory T cells.抗CD25单克隆抗体通过抑制CD4CD25Foxp3调节性T细胞增强日本血吸虫谷胱甘肽S-转移酶疫苗的保护效力。
Parasitol Res. 2017 Oct;116(10):2727-2732. doi: 10.1007/s00436-017-5581-0. Epub 2017 Aug 21.
8
IL-18 enhances protective effect in mice immunized with a Schistosoma japonicum FABP DNA vaccine.白细胞介素-18增强日本血吸虫脂肪酸结合蛋白DNA疫苗免疫小鼠的保护作用。
Acta Trop. 2009 Sep;111(3):284-8. doi: 10.1016/j.actatropica.2009.03.010. Epub 2009 May 23.
9
[Effect and mechanism of CD4CD25 regulatory T cells on protective efficacy of protein vaccine against in mice].[CD4CD25调节性T细胞对蛋白质疫苗在小鼠中抗……保护效力的影响及机制] (原文中“against”后内容缺失)
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2016 May 20;28(3):269-274. doi: 10.16250/j.32.1374.2015150.
10
Dynamics of Th17 cells and their role in Schistosoma japonicum infection in C57BL/6 mice.Th17 细胞的动态变化及其在感染日本血吸虫的 C57BL/6 小鼠中的作用。
PLoS Negl Trop Dis. 2011 Nov;5(11):e1399. doi: 10.1371/journal.pntd.0001399. Epub 2011 Nov 15.

引用本文的文献

1
Transmission-Blocking Vaccines against Schistosomiasis Japonica.日本血吸虫病传播阻断疫苗。
Int J Mol Sci. 2024 Jan 30;25(3):1707. doi: 10.3390/ijms25031707.
2
A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice.一种低剂量腺病毒载体疫苗,表达曼氏血吸虫组织蛋白酶 B,可预防小鼠的肠道血吸虫病。
EBioMedicine. 2022 Jun;80:104036. doi: 10.1016/j.ebiom.2022.104036. Epub 2022 Apr 30.
3
Adjuvanted -Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model.

本文引用的文献

1
Effect of regulatory T cells on the efficacy of the fatty acid-binding protein vaccine against Schistosoma japonicum.调节性 T 细胞对脂肪酸结合蛋白疫苗防治日本血吸虫效果的影响。
Parasitol Res. 2019 Feb;118(2):559-566. doi: 10.1007/s00436-018-6186-y. Epub 2019 Jan 4.
2
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody.通过 Fc 工程化抗 CTLA-4 抗体对肿瘤免疫中的人 Treg 和效应 T 细胞进行差异化控制。
Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):609-618. doi: 10.1073/pnas.1812186116. Epub 2018 Dec 26.
3
Current Status of the Sm14/GLA-SE Schistosomiasis Vaccine: Overcoming Barriers and Paradigms towards the First Anti-Parasitic Human(itarian) Vaccine.
佐剂化 - 半胱氨酸蛋白酶 B 与硫酸化乳糖基古生菌囊泡或 AddaVax™ 在临床前血吸虫病模型中提供保护。
Front Immunol. 2020 Nov 16;11:605288. doi: 10.3389/fimmu.2020.605288. eCollection 2020.
Sm14/GLA-SE血吸虫病疫苗的现状:克服迈向首款抗寄生虫人类(人道)疫苗的障碍与范式
Trop Med Infect Dis. 2018 Nov 21;3(4):121. doi: 10.3390/tropicalmed3040121.
4
DNA vaccination using recombinant Schistosoma mansoni fatty acid binding protein (smFABP) gene.使用重组曼氏血吸虫脂肪酸结合蛋白(smFABP)基因进行DNA疫苗接种。
Exp Parasitol. 2018 Nov;194:53-59. doi: 10.1016/j.exppara.2018.09.018. Epub 2018 Sep 25.
5
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3 Regulatory T Cells (Tregs) in Human Cancers.抗 CTLA-4 免疫疗法不会耗尽人类癌症中的 FOXP3+调节性 T 细胞(Tregs)。
Clin Cancer Res. 2019 Feb 15;25(4):1233-1238. doi: 10.1158/1078-0432.CCR-18-0762. Epub 2018 Jul 27.
6
Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer.MUC1 mRNA 纳米疫苗联合 CTLA-4 阻断的免疫治疗有效抑制三阴性乳腺癌的生长。
Mol Ther. 2018 Jan 3;26(1):45-55. doi: 10.1016/j.ymthe.2017.10.020. Epub 2017 Dec 5.
7
CTLA-4: a moving target in immunotherapy.CTLA-4:免疫疗法中的一个移动靶标。
Blood. 2018 Jan 4;131(1):58-67. doi: 10.1182/blood-2017-06-741033. Epub 2017 Nov 8.
8
Anti-CD25 monoclonal antibody enhances the protective efficacy of Schistosoma japonicum GST vaccine via inhibition of CD4CD25Foxp3 regulatory T cells.抗CD25单克隆抗体通过抑制CD4CD25Foxp3调节性T细胞增强日本血吸虫谷胱甘肽S-转移酶疫苗的保护效力。
Parasitol Res. 2017 Oct;116(10):2727-2732. doi: 10.1007/s00436-017-5581-0. Epub 2017 Aug 21.
9
[Immune-related adverse events by immune checkpoint inhibitors].免疫检查点抑制剂相关的免疫不良反应
Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(2):83-89. doi: 10.2177/jsci.40.83.
10
Enhancement of antitumor immunity by combination of anti-CTLA-4 antibody and radioimmunotherapy through the suppression of Tregs.通过抑制调节性T细胞,联合使用抗CTLA-4抗体与放射免疫疗法增强抗肿瘤免疫力。
Oncol Lett. 2017 May;13(5):3781-3786. doi: 10.3892/ol.2017.5933. Epub 2017 Mar 28.